The weekly cost of nausea and vomiting of pregnancy for women calling the Toronto Motherisk Program

Current Medical Research and Opinion

Volumn 23, Issue 4, 2007, Pages 833-840

  Piwko, Charles ^a,b,d   Ungar, Wendy J ^a,b   Einarson, Thomas R ^b   Wolpin, Jacob ^c   Koren, Gideon ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c YORK UNIVERSITY   (Canada)

^d PharmIdeas Research and Consulting Inc   (Canada)

Author keywords

Canada; Nausea and vomiting; Pregnancy; Weekly costs

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANADA; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; MAJOR CLINICAL STUDY; NAUSEA AND VOMITING; PREGNANCY; PREGNANT WOMAN;

ADOLESCENT; ADULT; CANADA; COST OF ILLNESS; EFFICIENCY; FEMALE; HEALTH CARE COSTS; HOTLINES; HUMANS; MORNING SICKNESS; PREGNANCY; TIME FACTORS;

EID: 34247335805     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079907X178739     Document Type: Article

References (28)

1. Koren G. Preface. In: Koren G, Bishai R, editors. Nausea and vomiting of pregnancy, state of the art (Vol. 1). Toronto: Motherisk, the Hospital for Sick Children, 2000:xvii
2. Van Dadelszen P. The etiology of nausea and vomiting of pregnancy. In: Koren G, Bishai R, editors. Nausea and vomiting of pregnancy, state of the art (Vol. 1). Toronto: Motherisk, the Hospital for Sick Children, 2000. pp.5-9
3. O'Brien B, Naber S. Nausea and vomiting in pregnancy: effects on die quality of women's lives. Birth 1992;19:138-43
4. Gadsby R, Bamie-Adshead AM, Jagger C. A prospective study of nausea and vomiting during pregnancy. Br J Gen Pract 1993;43:245-8
5. Bishai R, Mazzotta P, Atanackovic G, et al. Critical appraisal of drug therapy for nausea and vomiting of pregnancy: II. Efficacy and safety of diclectin (doxylamine-B6). Can J Clin Pharmacol 2000;7:138-43
6. Mazzotta P, Magee LA. A risk-benefit assessment of pharmacological and non-pharmacological treatments for nausea and vomiting of pregnancy. Drugs 2000;59:781-800
7. Attard CL, Kohli MA, Coleman S, et al. The burden of illness of severe nausea and vomiting of pregnancy in the United States. Am J Obstet Gynecol 2002;186:220-27
8. Tiran D. Nausea and vomiting in pregnancy: safety and efficacy or self-administered complementary therapies. Complement Ther Nurs Midwifery 2002;8:191-6
9. De la Ronde S. Nausea and vomiting in pregnancy. J SOGC 1994;16:2035-41
10. Arsenault MY, Lane CA, MacKinnon CJ, et al. The management of nausea and vomiting of pregnancy. J Obstet Gynaecol Can 2002;24:817-33
11. Gadsby R. A prospective study of nausea and vomiting in pregnancy. In: Koren G, Bishai R, editors. Nausea and vomiting of pregnancy, state of the art (Vol. 1). Toronto: Motherisk, the Hospital for Sick Children, 2000. pp.27-30
12. Vellacott ID, Cooke E, James CE. Nausea and vomiting in early pregnancy. Int J Gynecol Obstet 1998;27:57-62
13. Deuchar N. Nausea and vomiting in pregnancy: a review of the problem with particular regard to psychological and social aspects. Br J Obstet Gynecol 1995;102:6-8
14. Weigel RM. Nausea and vomiting in pregnancy and pregnancy outcome: an epidemiological overview. In: Koren G, Bishai R, editors. Nausea and vomiting of pregnancy, state of the art (Vol. 1). Toronto: Motherisk, the Hospital for Sick Children, 2000. pp.41-6
15. Rhodes V and McDaniel R. The index of nausea, vomiting and retching: a new format of the index of nausea and vomiting. Oncol Nurs Forum 1999;26:889-94
16. Koren G, Boskovic R, Hard M, et al. Motherisk PUQE scoring system for nausea and vomiting of pregnancy. Am J Obstet Gynecol 2002;186:228-35
17. Consumer Price Index. Available from http://cansim2.statcan.ca [Last accessed 9 November 2006]
18. Drummond MF, O'Brien B, Stoddart GL, et al. Methods for the economic evaluation of health care programmes. 2nd edn. Oxford: Oxford Medical Publication, Oxford University Press, 1997
19. Ungar WJ, Coyte PC, Chapman KR, et al. The patient level cost of asthma in adults in south central Ontario. Can Respir J 1998;5:463-71
20. Hodgson TA. Cost of illness in cost effectiveness analysis, a review of the methodology. Pharmacoeconomics 1994;6:536-52
21. Liljas B. How to calculate indirect costs in economic evaluations. Pharmacoeconomics 1998;13:1-7
22. van Roijen L, Essink-Bot ML, Koopmanschap MA, et al. Labor and health status in economic evaluation of health care. The Health and Labor Questionnaire. Int J Technol Assess Health Care 1996;12:405-15
23. Statistics Canada, average hourly wages of employees by selected characteristics and profession, unadjusted data, by province, available at http://www40.statcan.ca/101/cst01/labr69a.htm [Last accessed 25 January 2003]
24. Ungar WJ, Coyte PC, and the Pharmacy Medication Monitoring Program Advisory Board. Measuring productivity loss days in asthma patients. Health Econ 2000,9:37-46
25. The Society of Obstetricians and Gynaecologists of Canada (SOGC), availableat: http://sogc.medical.org/healthybeginnings/qfacts.htm [Last accessed 26 September 2004]
26. The Government of Canada's report Early Childhood Development Activities and Expenditures: Government of Canada Report 2001-2002 in the section 'A portrait of Canadian families', available at: http://socialunion.ca/ecd/2002/b- 3.htm [Last accessed 02 September 2004]
27. Statistics Canada, Teenage pregnancy, available at http://www.statcan.ca/ english/kits/preg/preg3.htm [Last accessed 02 September 2004]
28. Health Canada in MEASURING UP - Teen Pregnancy in 1996, available at http://www.phac-aspc.gc.ca/publicat/meas-haut/mu_ee_e.html [Last accessed 02 September 2004]